Daundong, Perlyn .
HRN: 26-05-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/09/2024
11/15/2024
IV
500mg
Q6h
Hepatic Abscess Metronidazole X 14days Already Completed, Plan To Extend Until 21 Days
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes